These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35938144)

  • 1. Consecutive central and branch retinal vein occlusions in the same eye of a young healthy COVID-19 patient: A unique case report.
    Altıntaş AG; Ekici E
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101669. PubMed ID: 35938144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Branch Retinal Vein Occlusion Post-mRNA SARS-CoV-2 (COVID-19) Vaccination.
    Lee J; Ong KW; Wan Abdul Halim WH; Mohd Khialdin S; Yong MH
    Optom Vis Sci; 2023 Nov; 100(11):799-803. PubMed ID: 37844608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
    Simsek M; Citirik M; Ozates S; Ozkoyuncu D
    Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
    Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
    Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study.
    Costa JV; Moura-Coelho N; Abreu AC; Neves P; Ornelas M; Furtado MJ
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):343-350. PubMed ID: 32965652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
    Papadia M; Misteli M; Jeannin B; Herbort CP
    Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term efficacy and safety of ranibizumab for macular oedema secondary to retinal vein occlusion in Japanese patients.
    Kamei M; Terasaki H; Yoshimura N; Shiraga F; Ogura Y; Grotzfeld AS; Pilz S; Ishibashi T
    Acta Ophthalmol; 2017 Feb; 95(1):e29-e35. PubMed ID: 27654837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Background of a Recurrent Unusual Combined Form of Retinal Vein Occlusion: A Case Report.
    Bucan K; Plestina Borjan I; Bucan I; Paradzik Simunovic M; Borjan I
    Case Rep Ophthalmol; 2018; 9(1):248-253. PubMed ID: 29805379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitrectomy for macular edema due to retinal vein occlusion.
    Kumagai K; Ogino N; Fukami M; Furukawa M
    Clin Ophthalmol; 2019; 13():969-984. PubMed ID: 31354231
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 19. Central Retinal Vein Occlusion after mRNA COVID-19 Vaccination.
    Ishiguro K; Hirano Y; Esaki Y; Yasukawa T
    Case Rep Ophthalmol; 2023; 14(1):234-240. PubMed ID: 37383170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.